Sonoma Pharmaceuticals (SNOA)
(Delayed Data from NSDQ)
$0.42 USD
+0.12 (37.34%)
Updated Jul 22, 2024 03:59 PM ET
After-Market: $0.42 0.00 (-0.71%) 6:56 PM ET
1-Strong Buy of 5 1
F Value C Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SNOA 0.42 +0.12(37.34%)
Will SNOA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SNOA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNOA
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum
Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock
SNOA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SNOA
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Sonoma Pharmaceuticals price target lowered by $1.75 at Ladenburg, here's why
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session